Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G) - A new designer drug

Drug Testing and Analysis

Volumn 5, Issue 7, 2013, Pages 549-559

  Zuba, Dariusz ^a   Sekula, Karolina ^a  

^a INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

Designer drugs; Identification; Legal highs; Phenethylamines

Indexed keywords

ELECTROSPRAY IONIZATION; FOURIER SERIES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; IONIZATION OF GASES; IONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

DESIGNER DRUGS; ELECTRON IMPACT MASS SPECTROMETRY; IDENTIFICATION; INFRARED SPECTROSCOPIC; LEGAL HIGH; PHENETHYLAMINES; POWDER SAMPLES; RELATIVE INTENSITY; SPECTRA'S; SPECTROSCOPIC DATA;

GAS CHROMATOGRAPHY;

2,5 DIMETHOXY 3,4 DIMETHYL BETA PHENETHYLAMINE; DESIGNER DRUG; UNCLASSIFIED DRUG;

ARTICLE; DRUG IDENTIFICATION; ELECTROSPRAY MASS SPECTROMETRY; FOURIER TRANSFORMATION; INFRARED SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLAND; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84880147510     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1396     Document Type: Article

References (42)

1. L.A. King, A.T. Kicman. A brief history of 'new psychoactive substances'. Drug Test. Anal. 2011, 3, 401.
2. S.D. Brandt, H.R. Sumnall, F. Measham, J. Cole. Analyses of second generation 'legal highs' in the UK: initial findings. Drug Test. Anal. 2010, 2, 377.
3. B. Byrska, D. Zuba, R. Stanaszek. Determination of piperazine derivatives in 'legal highs'. Probl. Forensic Sci. 2010, 82, 101.
4. G. De Paoli, P.D. Maskell, D.J. Pounder. Naphyrone: Analytical profile of the new "legal high" substitute for mephedrone. J. Forensic Legal Med. 2011, 18, 93.
5. P. Jankovics, A. Varadi, L. Tolgyesi, S. Lohner, J. Nemeth-Palotas, H. Koszegi-Szalai. Identification and characterization of the new designer drug 4-methylethcathinone (4-MEC) and elaboration of a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening method for seven different methcathinone analogs. Forensic Sci. Int. 2011, 210, 213.
6. S.D. McDermott, J.D. Power, P. Kavanagh, J. O'Brien. The analysis of substituted cathinones. Part 2: An investigation into the phenylacetone based isomers of 4-methylmethcathinone and N-ethylcathinone. Forensic Sci. Int. 2011, 212, 13.
7. S.P. Stewart, S.E.J. Bell, N.C. Fletcher, S. Bouazzaoui, Y.C. Ho, S.J. Speers, et al. Raman spectroscopy for forensic examination of β-ketophenethylamine 'legal highs': Reference and seized samples of cathinone derivatives. Anal. Chim. Acta 2012, 711, 1.
8. F. Westphal, T. Junge, U. Girreser, W. Greibl, C. Doering. Mass, NMR and IR spectroscopic characterization of pentedrone and pentylone and identification of their isocathinone by-products. Forensic Sci. Int. 2012, 217, 157.
9. R. Stanaszek, D. Zuba. 1-(3-chlorophenyl)piperazine (mCPP)-a new designer drug that is still a legal substance. Probl. Forensic Sci. 2006, 66, 220.
10. D. Zuba. Identification of cathinones and other active components of 'legal highs' by mass spectrometric methods, Trends Anal. Chem. 2012, 32, 15.
11. M.D. Cole, C. Lea, N. Oxley. 4-Bromo-2, 5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. Sci. Justice 2002, 42, 223.
12. Wikipedia. Available at: http://en.wikipedia.org/wiki/2C-E [17 February 2012].
13. D. de Boer, I. Bosman. A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharm. World Sci. 2004, 26, 110.
14. G. Boatto, M. Nieddu, G. Dessì, P. Manconi, R. Cerri. Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection. J. Chromatogr. A 2007, 1159, 198.
15. Y.C. Chiu, S.H. Chou, J.T. Liu, C.H. Lin. The bioactivity of 2, 5-dimethoxy-4-ethylthiophenethylamine (2C-T-2) and its detection in rat urine by capillary electrophoresis combined with an on-line sample concentration technique. J. Chromatogr. B 2004, 811, 27.
16. D.S. Theobald, H.H. Maurer. Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series). Biochem. Pharmacol. 2007, 73, 287.
17. B. Curtis, P. Kemp, L. Harty, C. Choi, D. Christensen. Postmortem identification and quantitation of 2, 5-dimethoxy-4-n-propylthiophenethylamine using GC-MSD and GC-NPD. J. Anal. Toxicol. 2003, 27, 493.
18. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs, 2004.
19. D.S. Theobald, H.H. Maurer. Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2, 5-dimethoxy-β-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques. J. Chromatogr. B 2006, 842, 76.
20. J.J. Chambers, D.E. Nichols. A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor. J. Comput. Aided Mol. Des. 2002, 16, 511.
21. G. Beuerle, K.A. Kovar, M. Schulze-Alexandru. Three-dimensional quantitative structure-activity relationships of hallucinogenic phenylalkanamine and tryptamine derivatives. Studies using comparative molecular field analysis (CoMFA). Quant. Struct.-Act. Relat. 1997, 16, 447.
22. B.W. Clare. The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens. J. Med. Chem. 1998, 41, 3845.
23. R.A. Glennon, L.B. Kier, A.T. Shulgin. Molecular connectivity analysis of halluciogenic mescaline analogs. J. Pharm. Sci. 1979, 68, 906.
24. S.P. Gupta, M.C. Bindal, P. Singh. Quantitative structure-activity studies on hallucinogenic mescaline analogs using modified first order valence connectivity. Arzneimittelforschung 1982, 32, 1223.
25. L.B. Kier, R.A. Glennon. Progress with several models for the study of the SAR of hallucinogenic agents. NIDA Res. Monogr. 1978, 22, 159.
26. G. Klopman, O.T. Macina. Use of the Computer Automated Structure Evaluation program in determining quantitative structure-activity relationships within hallucinogenic phenylalkylamines. J. Theor. Biol. 1985, 113, 637.
27. M. Mracec, M. Mracec, L. Kurunczi, T. Nusser, Z. Simon, G. Naray-Szabo. QSAR study with steric (MTD), electronic and hydrophobicity parameters on psychotomimetic phenylalkylamines. Theochem, 1996, 367, 139.
28. M. Thakur, A. Thakur, P.V. Khadikar. QSAR studies on psychotomimetic phenylalkylamines. Bioorgan. Med. Chem. 2004, 12, 825.
29. K. Neuvonen, H. Neuvonen, F. Fulop. Effect of 4-substitution on psychotomimetic activity of 2, 5-dimethoxy amphetamines as studied by means of different substituent parameter scales. Bioorg. Med. Chem. Lett. 2006, 16, 3495.
30. P. Jacob III, A.T. Shulgin. Structure-activity relationships of the classic hallucinogens and their analogs. NIDA Res. Monogr. 1994, 146, 74.
31. A.R. Blaazer, P. Smid, C.G. Kruse. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors. ChemMedChem 2008, 3, 1299.
32. P. Jacob III, A.T. Shulgin. The ethyl homologues of mescaline and their monothio analogues. J. Med. Chem. 1984, 27, 881.
33. A. Shulgin, A. Shulgin. Phenethylamines I Have Known And Loved: A Chemical Love Story. Transform Press, Berkeley, CA, 1991.
34. Wikipedia. Available at: http://en.wikipedia.org/wiki/2C-G [17 February 2012].
35. R.A. Glennon, R. Young, F. Benington, R.D. Morin. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2, 5-dimethoxyphenyl)-2-aminopropane. J. Med. Chem. 1982, 25, 1163.
36. A.T. Shulgin, T. Sargent, C. Naranjo. 4-Bromo-2, 5-dimethoxyphenylisopropylamine - A new centrally active amphetamine analog. Pharmacology 1971, 5, 103.
37. A.H. Lewin, H.A. Navarro, S.W. Mascarella. Structure-activity correlations for β-phenethylamines at human trace amine receptor 1. Bioorgan. Med. Chem. 2008, 16, 7415.
38. J.C. Parrish, M.R. Braden, E. Gundy, D.E. Nichols. Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists. J. Neurochem. 2005, 95, 1575.
39. B.H. Chen, J.T. Liu, W.X. Chen, H.M. Chen, C.H. Lin. A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. Talanta 2008, 74, 512.
40. S.D. Brandt, P.F. Daley, N.V. Cozzi. Analytical characterization of three trifluoromethyl-substituted methcathinone isomers. Drug Test. Anal. 2012, 4, 525.
41. W.H. Soine, W. Duncan, R. Lambert, R. Middleberg, H. Finley, D.J. O'Neil. Differentiation of side chain isomers of ring-substituted amphetamines using gas chromatography/infrared/mass spectrometry (GC/IR/MS). J. Forensic Sci. 1992, 37, 513.
42. J. Coates. Interpretation of Infrared Spectra, A Practical Approach. in Encyclopedia of Analytical Chemistry, (Ed. R.A. Meyers ). John Wiley & Sons Ltd, Chichester, UK, 2000, pp. 10815-10837.